Trial NCT02914938

View at ClinicalTrials.gov 
Org. Study IDs: ME-401-002

Last trial update was posted on 2023-05-09

MeSH Interventions

Rituximab Zanubrutinib

MeSH Conditions

Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma Lymphoma, B-Cell Lymphoma, B-Cell, Marginal Zone Lymphoma, Large B-Cell, Diffuse Lymphoma, Mantle-Cell Lymphoma, Non-Hodgkin

Other Conditions

Chronic Lymphocytic Leukemia (CLL) Diffuse Large B-cell Lymphoma (DLBCL) Follicular Lymphoma (FL) High Grade Non-Hodgkin's Lymphoma Mantle Cell Lymphoma (MCL) Marginal Zone B Cell Lymphoma Small Lymphocytic Lymphoma (SLL)

Stopping Reasons

discontinuation of zandelisib program

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID